Alnylam Pharmaceuticals, Inc. (ALNY) vs IDEXX Laboratories, Inc. (IDXX)
IDXX leads on 9 of 14 compared metrics.
A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
ALNY
Alnylam Pharmaceuticals, Inc.
$281.19HealthcareDelayed quote: Jul 15, 2026, 10:50 AM EDT
IDXX
IDEXX Laboratories, Inc.
$562.02HealthcareDelayed quote: Jul 15, 2026, 10:50 AM EDT
Total return — ALNY vs IDXX
growth of $100 · dividends reinvested · last 22yALNY +4579.9%IDXX +3453.6%ALNY compounded faster
ALNY IDXX
ALNY vs IDXX: by the numbers
- •IDXX is the larger company ($44.33B vs $37.54B market cap).
- •IDXX trades at the lower earnings multiple (39.87 vs 66.81 P/E).
- •IDXX converts more revenue to profit (24.63% vs 13.46% net margin).
- •ALNY grew revenue faster over the past five years (49.67% vs 9.24% CAGR).
Which is better, ALNY or IDXX?
Metric tally: ALNY 5 · IDXX 9It depends on what you're optimizing for:
ValueIDXX(lower P/E)
GrowthALNY(faster 5Y revenue CAGR)
QualityIDXX(higher ROIC)
Metrics side by side
Valuation
| Metric | ALNY | IDXX |
|---|---|---|
| P/E ratio | 66.81 | 39.87● |
| Forward P/E | 37.91 | 36.91● |
| P/S ratio | 9.07● | 9.81 |
| P/B ratio | 36.15 | 28.03● |
| PEG ratio | — | 2.31 |
| EV / EBITDA | 47.64 | 28.64● |
| FCF yield | 1.65% | 2.48%● |
Profitability
| Metric | ALNY | IDXX |
|---|---|---|
| Gross margin | 80.89%● | 62.05% |
| Operating margin | 17.54% | 31.63%● |
| Net margin | 13.46% | 24.63%● |
| ROE | 53.68% | 70.38%● |
| ROIC | 13.74% | 40.27%● |
Growth (annualized)
| Metric | ALNY | IDXX |
|---|---|---|
| Revenue CAGR (5Y) | 49.67%● | 9.24% |
| EPS CAGR (5Y) | — | 14.07% |
| FCF CAGR (5Y) | 14.35%● | 10.13% |
| Total return CAGR (5Y) | 10.55%● | -3.91% |
Frequently asked
- Which is better, ALNY or IDXX?
- It depends on your goal. value: IDXX (lower P/E); growth: ALNY (faster 5Y revenue CAGR); quality: IDXX (higher ROIC). Across all compared metrics, IDXX leads 9 to 5.
- Is ALNY or IDXX cheaper?
- On trailing earnings, IDXX is cheaper: ALNY trades at a 66.81 P/E and IDXX at 39.87.
- Which has grown faster, ALNY or IDXX?
- Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus IDXX at 9.24%.
- Is ALNY or IDXX more profitable?
- IDXX runs the higher net margin — ALNY at 13.46% versus IDXX at 24.63%.
- Which has been the better investment, ALNY or IDXX?
- Over the past 10-year, IDXX delivered the higher annualized total return — ALNY at 16.14% versus IDXX at 19.22%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alnylam Pharmaceuticals P/E ratioIDEXX Laboratories P/E ratioAlnylam Pharmaceuticals dividend yieldIDEXX Laboratories dividend yieldAlnylam Pharmaceuticals ROEIDEXX Laboratories ROEAlnylam Pharmaceuticals operating marginIDEXX Laboratories operating marginAlnylam Pharmaceuticals revenue growthIDEXX Laboratories revenue growthAlnylam Pharmaceuticals free cash flowIDEXX Laboratories free cash flow
Alnylam Pharmaceuticals & IDEXX Laboratories appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 15, 2026.